ES547115A0 - Procedimiento para producir una composicion viral ateunada viva uniforme de hepatitis a. - Google Patents

Procedimiento para producir una composicion viral ateunada viva uniforme de hepatitis a.

Info

Publication number
ES547115A0
ES547115A0 ES547115A ES547115A ES547115A0 ES 547115 A0 ES547115 A0 ES 547115A0 ES 547115 A ES547115 A ES 547115A ES 547115 A ES547115 A ES 547115A ES 547115 A0 ES547115 A0 ES 547115A0
Authority
ES
Spain
Prior art keywords
hepatitis
procedure
producing
attenuated viral
viral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547115A
Other languages
English (en)
Other versions
ES8701837A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Government
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24615385&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES547115(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of ES547115A0 publication Critical patent/ES547115A0/es
Publication of ES8701837A1 publication Critical patent/ES8701837A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32461—Methods of inactivation or attenuation
    • C12N2770/32464—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ES547115A 1984-09-19 1985-09-19 Procedimiento para producir una composicion viral ateunada viva uniforme de hepatitis a. Expired ES8701837A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/652,067 US4620978A (en) 1982-04-07 1984-09-19 Hepatitis A virus purified and triply cloned

Publications (2)

Publication Number Publication Date
ES547115A0 true ES547115A0 (es) 1986-12-01
ES8701837A1 ES8701837A1 (es) 1986-12-01

Family

ID=24615385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547115A Expired ES8701837A1 (es) 1984-09-19 1985-09-19 Procedimiento para producir una composicion viral ateunada viva uniforme de hepatitis a.

Country Status (16)

Country Link
US (1) US4620978A (es)
EP (1) EP0196316A4 (es)
JP (1) JPS62500659A (es)
KR (1) KR860700263A (es)
AU (1) AU583306B2 (es)
CA (1) CA1260392A (es)
DK (1) DK227786A (es)
ES (1) ES8701837A1 (es)
FI (1) FI86376C (es)
GR (1) GR852293B (es)
IL (1) IL76417A (es)
NO (1) NO169601C (es)
NZ (1) NZ213513A (es)
PT (1) PT81150B (es)
WO (1) WO1986001826A1 (es)
ZA (1) ZA857134B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894228A (en) * 1982-04-07 1990-01-16 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
USRE37381E1 (en) * 1982-04-07 2001-09-18 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
WO1994006446A1 (en) 1992-09-18 1994-03-31 Smithkline Beecham Biologicals, S.A. Hepatitis a virus vaccines
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5766906A (en) * 1994-07-11 1998-06-16 The University Of North Carolina At Chapel Hill Hepatitis A virus deletion mutants and vaccine formulations containing the same
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175

Also Published As

Publication number Publication date
NO169601C (no) 1992-07-15
FI86376B (fi) 1992-05-15
PT81150B (pt) 1987-10-20
IL76417A0 (en) 1986-01-31
FI86376C (fi) 1992-08-25
FI861966A0 (fi) 1986-05-12
NZ213513A (en) 1989-03-29
EP0196316A1 (en) 1986-10-08
CA1260392A (en) 1989-09-26
AU583306B2 (en) 1989-04-27
EP0196316A4 (en) 1987-01-28
ZA857134B (en) 1987-05-27
NO861619A (no) 1986-04-24
DK227786D0 (da) 1986-05-16
FI861966A (fi) 1986-05-12
US4620978A (en) 1986-11-04
WO1986001826A1 (en) 1986-03-27
ES8701837A1 (es) 1986-12-01
GR852293B (es) 1986-01-21
KR860700263A (ko) 1986-08-01
JPS62500659A (ja) 1987-03-19
AU4862085A (en) 1986-04-08
PT81150A (en) 1985-10-01
IL76417A (en) 1990-12-23
DK227786A (da) 1986-05-16
NO169601B1 (no) 1992-04-06

Similar Documents

Publication Publication Date Title
ES484124A0 (es) Procedimiento para la preparacion de una composicion homoge-nea destinada al tratamiento de materias fibrosas.
MX161768A (es) Procedimiento para preparar una composicion desinfectante
ES542428A0 (es) Procedimiento de preparacion de una olefina polisulfurada.
NO892226D0 (no) Sementsammensetning herdbar ved lave temperaturer.
ES539366A0 (es) Procedimiento para preparar una composicion de revestimiento de poliureanuretano
IT1105404B (it) Procedimento per la produzione di una composizione catalizzatrice
ES553764A0 (es) Un procedimiento para fabricar un articulo de una composicion fotopolimerizable.
DE3584021D1 (de) Dentale materialien.
ES554625A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
IT1219684B (it) Procedimento per preparare una composizione cementizia ad alta resistenza
ES521835A0 (es) Procedimiento para producir una hoja continua de fibras extremadamente uniforme.
ES497825A0 (es) Un procedimiento para la produccion de una composicion de silicona.
ES544615A0 (es) Procedimiento para preparar una composicion antiacido
ES544672A0 (es) Un procedimiento para preparar una composicion de esmalte deunas
ES552286A0 (es) Procedimiento de obtencion de una composicion de revestimiento decorativo.
NO166416C (no) Fremgangsmaate ved fremstilling av cellulosemasse.
ES547115A0 (es) Procedimiento para producir una composicion viral ateunada viva uniforme de hepatitis a.
NO854657L (no) Fremgangsmaate ved fremstilling av isosilybinfri silibin.
AR240303A1 (es) Una silice, procedimiento para su preparacion y composicion dentifrica que la contiene.
ES540379A0 (es) Un procedimiento para la preparacion de una composicion de amidas de acidos carboxilicos y de acidos fosforicos organicos.
ES556001A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
ES542019A0 (es) Procedimiento para producir una n-acilfenilalanina
ES527588A0 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
ES554236A0 (es) Procedimiento para la fabricacion de una lamina compuesta metalizada.
DE68924137D1 (de) Zusammenbau einer Indirekt geheizten Kathode.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20061003